Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 1051 to 1075 of 1160 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
110 decreased vitellogenins (MESH:D014819) 221: Reduction, Plasma vitellogenin concentrations
109 decreased egg quantity (VT:1000294)
108 decreased gene expression (GO:0010467) vitellogenins (MESH:D014819) 285: Reduction, Vitellogenin synthesis in liver
107 increased androgen receptor activity (GO:0004882) androgen receptor (PR:000004191) 25: Agonism, Androgen receptor
106 increased gene expression (GO:0010467) prostaglandin G/H synthase 2 (PR:000013428) 1269: Increase, COX-2 expression
105 morphological change abnormal cardiovascular system physiology (MP:0001544) 317: Altered, Cardiovascular development/function
104 morphological change developmental process (GO:0032502) cardiovascular system (UBERON:0004535) None
103 disrupted protein dimerization activity (GO:0046983) aryl hydrocarbon receptor nuclear translocator (PR:000004303) None
102 disrupted protein dimerization activity (GO:0046983) aryl hydrocarbon receptor (PR:000003858) None
101 increased aryl hydrocarbon receptor activity (GO:0004874) aryl hydrocarbon receptor (PR:000003858) 18: Activation, AhR
100 decreased fertility (MESH:D005298)
99 decreased regulation of gene expression (GO:0010468) androgen receptor (PR:000004191) 286: Altered, Transcription of genes by the androgen receptor
98 arrested developmental process (GO:0032502) male reproductive organ (UBERON:0003135) 240: Feminisation or incomplete development, Primary and accessory male sex organs
97 abnormal Wnt signaling pathway (GO:0016055) Wnt signalosome (GO:1990909) 310: Alteration, Wnt pathway
96 decreased androgen receptor activity (GO:0004882) androgen receptor (PR:000004191)
95 morphological change male reproductive organ (UBERON:0003135) 348: Malformation, Male reproductive tract
94 decreased testosterone (CHEBI:17347)
93 decreased testosterone biosynthetic process (GO:0061370) testosterone (CHEBI:17347)
92 decreased mitochondrial transport (GO:0006839) cholesterol (CHEBI:16113) 447: Reduction, Cholesterol transport in mitochondria
91 decreased gene expression (GO:0010467) translocator protein (PR:000016757) 289: Decrease, Translocator protein (TSPO)
90 decreased gene expression (GO:0010467) STAR (PR:000015715) 266: Decrease, Steroidogenic acute regulatory protein (STAR)
89 increased peroxisome proliferator activated receptor signaling pathway (GO:0035357) peroxisome proliferator-activated receptor alpha (PR:000013056) 227: Activation, PPARα
88 increased neuron death in response to oxidative stress (GO:0036475) 191: Neuronal dysfunction
87 occurrence oxidative stress (MP:0003674) None
86 decreased glutathione (CHEBI:16856) None